Inify Laboratories AB
Provides cancer diagnostics using a digital, AI-supported pathology workflow.
INIFY | ST
Overview
Corporate Details
- ISIN(s):
- SE0017486103
- LEI:
- 549300306YYJ3BX3VB98
- Country:
- Sweden
- Address:
- Scheeles väg 3, 171 65 Solna
- Website:
- https://www.inify.com/
- Industry:
- Other human health activities
Description
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. The company utilizes a fully digital, standardized, and AI-supported workflow for histopathology analysis. This integrated service model is designed to optimize the entire diagnostic process, from sample receipt to final report, ensuring high quality and significantly reduced turnaround times for clinical partners. Initially focused on prostate cancer, the company has expanded its diagnostic capabilities to include other areas such as gastroenterology. By streamlining the clinical pathway, Inify Laboratories enables healthcare providers to receive faster results, which facilitates earlier patient follow-up and treatment planning.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-09 08:00 |
Inify Laboratories announces application periods for fully guaranteed private p…
|
English | 225.5 KB | ||
| 2025-12-09 08:00 |
Inify Laboratories announces application periods for fully guaranteed private p…
|
English | 18.7 KB | ||
| 2025-12-09 08:00 |
Inify Laboratories announces application periods for fully guaranteed private p…
|
English | 225.5 KB | ||
| 2025-12-04 13:07 |
Kommuniké från extra bolagsstämma i Inify Laboratories AB - Attachment: Inify_L…
|
Swedish | 168.9 KB | ||
| 2025-12-04 13:07 |
Bulletin from the extraordinary general meeting of Inify Laboratories AB - Atta…
|
English | 174.9 KB | ||
| 2025-12-04 13:07 |
Kommuniké från extra bolagsstämma i Inify Laboratories AB
|
Swedish | 2.8 KB | ||
| 2025-12-04 13:07 |
Bulletin from the extraordinary general meeting of Inify Laboratories AB
|
English | 2.8 KB | ||
| 2025-12-04 13:07 |
Kommuniké från extra bolagsstämma i Inify Laboratories AB
|
Swedish | 168.9 KB | ||
| 2025-12-04 13:07 |
Bulletin from the extraordinary general meeting of Inify Laboratories AB
|
English | 174.9 KB | ||
| 2025-12-03 13:30 |
Inify Laboratories: Board announces updated timetable for settlement in propose…
|
English | 102.2 KB | ||
| 2025-12-03 13:30 |
Inify Laboratories: Board announces updated timetable for settlement in propose…
|
English | 15.5 KB | ||
| 2025-12-03 13:30 |
Inify Laboratories: Board announces updated timetable for settlement in propose…
|
English | 102.2 KB | ||
| 2025-11-28 10:57 |
Financial calendar
|
English | 690 bytes | ||
| 2025-11-28 10:57 |
Finansiell kalender
|
Norwegian | 671 bytes | ||
| 2025-11-12 15:09 |
Inify Laboratories - notice of Extraordinary General Meeting on December 4, 202…
|
Norwegian | 319.8 KB |
Automate Your Workflow. Get a real-time feed of all Inify Laboratories AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Inify Laboratories AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inify Laboratories AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-29 | Olof Sandén | Other | Buy | 10,000 | 44,800.00 SEK |
| 2025-01-27 | Olof Sandén | Other | Buy | 6,840 | 28,659.60 SEK |
| 2023-07-05 | Magne Jordanger | Other | Buy | 650,000 | 6,500,000.00 EUR |
| 2022-08-19 | Magne Jordanger | Other | Buy | 336,950 | 2,560,820.00 EUR |